Minerva Neurosciences, Inc. Balance Sheet
NERV|8 years of annual SEC 10-K data (FY2017-FY2024)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 8 fiscal years. All figures from audited SEC 10-K filings.
Minerva Neurosciences, Inc. had $37M in total assets with negative shareholders' equity of $26M as of FY2024.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -10.64 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $21.4M | $40.9M | $36.1M | $60.8M | $25.4M | $21.4M | $50.2M | $26.1M |
| Current Assets | $22.3M | $42.0M | $40.2M | $62.2M | $27.4M | $47.1M | $90.0M | $129.5M |
| PP&E (Net) | $5.4K | $10.9K | $16.3K | - | - | $16.0K | $33.5K | $50.9K |
| Goodwill | $14.9M | $14.9M | $14.9M | $14.9M | $14.9M | $14.9M | $14.9M | $14.9M |
| Total Assets | $37.1M | $56.9M | $55.1M | $77.1M | $57.6M | $77.5M | $139.1M | $183.7M |
| Current Liabilities | $2.8M | $3.3M | $1.4M | $2.8M | $3.2M | $6.6M | $3.6M | $6.8M |
| Shareholders' Equity | -$25.7M | -$20.0M | $8.0M | $52.7M | $27.8M | $90.3M | $131.6M | $106.0M |